Title : Metformin: a modulator of bevacizumab activity in cancer? A case report.

Pub. Date : 2015

PMID : 25607951






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These findings--albeit limited to a single case--suggest that tumors lacking LKB1 expression and/or endowed with an highly glycolytic phenotype might develop large necrotic areas following combined treatment with metformin plus bevacizumab. Metformin serine/threonine kinase 11 Homo sapiens